Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112920173A details a chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable manufacturing for oncology drug development.
Novel cobalt-catalyzed asymmetric Friedel-Crafts reaction for high-purity oxindoles. Cost-effective alternative to noble metals with scalable production capabilities.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Novel quinoline imidazole ligand enables high-yield asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Novel 5,5'-linked biphenyl ligands offering high stereoselectivity. Optimized synthesis for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Patent CN110452150B details a novel one-step synthesis of axial chiral indole-naphthalenes using chiral phosphoric acid, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high enantioselectivity. Ideal for anticancer drug development and cost-effective API manufacturing.
Patent CN110452150A reveals high-purity axial chiral indole-naphthalene synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable supply.
Patent CN114308121A discloses novel phosphine oxide catalysts enabling catalytic Mitsunobu reactions. Achieve high stereoselectivity, reduced waste, and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN113912618A reveals a novel base-catalyzed route for Dioxa[5]helicene. Achieve high purity and cost reduction in optoelectronic material manufacturing without transition metals.
Novel chiral phosphoric acid catalysis enables high-purity pharmaceutical intermediates with scalable production capabilities and significant cost reduction for global supply chains demanding reliable API intermediate sources.
Patent CN110467555A reveals chiral phosphoric acid catalysis for high-purity axial chiral arylindole compounds, offering cost reduction and supply chain reliability.
Advanced synthesis of chiral six-membered NHC precursor salts offering enhanced stability and catalytic efficiency for pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable API intermediate manufacturing.
Patent CN112209947A reveals a mild organocatalytic route for chiral indoxazinones with high enantioselectivity, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN118878543A reveals a novel synthesis for axial chiral compounds with high ee. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN118084763B reveals mild synthesis for high-purity intermediates. Enables cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Novel resolution method for axially chiral indole oxides offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.